Trending...
- Spokane: 2026 Safe Streets For All (Traffic Calming) Updates
- Cold. Clean. Anywhere. Meet FrostSkin
- Quality Expert Daryl Guberman Shatters Boeing's AS9100 Lies: 25 Years of Evidence Ignored by Media, Governments, and Legal Teams
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that two peer-reviewed publications using the GeoMx® Digital Spatial Profiler have been published in Nature and Nature Communications. These papers describe the use of Digital Spatial Profiling (DSP) technology to investigate SARS-CoV-2 infection and drive diagnostic, prevention, and treatment strategies.
The GeoMx DSP was used to profile lung tissue collected on autopsy from patients who had succumbed to COVID-19 infection. Researchers used the Cancer Transcriptome Atlas (CTA) plus a spike-in panel to detect additional lung genes and SARS-CoV-2 virus. In total, over 1,800 genes were interrogated as part of the study. This information enabled the researchers to connect bulk RNA sequencing data to the lung tissue's spatial architecture by looking at the distribution and transcriptional activity of cells, providing an important basis for understanding COVID-19 and lung pathology.
The first study, published in Nature Communications and led by Dr. Christopher Mason at Weill Cornell Medicine, was entitled "Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveal unique host responses, viral diversification, and drug interactions." In this study, the GeoMx platform was used to molecularly characterize alveolar lung tissue. The team found spatially-restricted expression of the gene ACE2—which is a SARS-CoV-2 cellular target—and SARS-CoV-2 virus in some of the same regions. From the spatially-resolved expression profiles, they were able to infer the abundance of different immune and non-immune cells and found unique cellular distributions in COVID-19 patients compared to normal control lung samples.
"We were interested in characterizing the diversity of SARS-CoV-2 circulating in the population as well as the diversity of response to infection within a single patient. By using cell-type deconvolution, we were able to measure relative levels of 16 different cell populations from COVID-19 cases and controls using a single slide from each patient," said Dr. Mason, who serves on NanoString's Scientific Advisory Board and is a paid consultant for the company. "This deep molecular profiling helped us create a more complete picture of how the virus circulates in the body and how it elicits a variable response in infected individuals."
More on Washingtoner
The second study, "The spatial landscape of lung pathology during COVID-19 progression", was published in Nature and was led by Dr. Robert Schwartz, Dr. Alain Borczuk, and Dr. Olivier Elemento at Weill Cornell Medicine. The team found a difference in immune composition between individuals with early (<14 days) versus late (>30 days) mortality after admission to a hospital with COVID-19 symptoms. In "early" patients, immune cells known as neutrophils were seen at rates comparable to other acute respiratory distress syndromes (ARDS). However, with time it appears that a different pattern emerges; namely, increased abundance of macrophages, more inflammation, and wound healing (fibrosis) in patients with late mortality.
"Spatial profiling of the samples allowed us to separately characterize the transcriptional response in the airway, alveolar, and vascular compartments of the lung, and enabled us to see that the early period of severe COVID-19 disease is comprised of inflammatory responses to SARS-CoV-2," said Dr. Schwartz. "We also discovered late COVID-19 might be driven by pathogen-independent mechanisms of an immune response with aberrant resolution."
"These studies demonstrate the value of the GeoMx Digital Spatial Profiler in characterizing the tissue damage induced by SARS-CoV-2 infection," said Sarah Warren, Ph.D., Senior Director of Translational Science at NanoString. "By applying high-plex molecular profiling on the formalin fixed, paraffin embedded (FFPE) tissues that are safe to work with from COVID-19 autopsies, we can understand how the virus is inducing and altering immune response and tissue repair in the patients' lungs."
The GeoMx Digital Spatial Profiler enables researchers to rapidly and quantitatively characterize tissue morphology with a high-throughput, high-plex RNA and protein profiling system that preserves precious samples for future analyses. NanoString and its collaborators have presented DSP data in dozens of abstracts at major scientific meetings, and in more than 40 peer reviewed publications, demonstrating DSP's utility to address a wide range of biological questions in FFPE and frozen tissues. Interested parties can learn more about DSP by visiting https://www.nanostring.com/scientific-content/technology-overview/digital-spatial-profiling-technology.
More on Washingtoner
NanoString launched its Technology Access Program (TAP) for the recently announced single and subcellular Spatial Molecular Imager to complement the existing TAP program for GeoMx. Under the program, customers can submit tissue samples to NanoString to be analyzed using both spatial profiling platforms and receive a complete data package. Researchers interested in participating in NanoString's Technology Access Program should contact the company at TAP@nanostring.com.
About NanoString Technologies, Inc.
NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company's nCounter® Analysis System is used in life sciences research and has been cited in more than 4,000 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company's GeoMx® Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections.
For more information, please visit www.nanostring.com.
NanoString, NanoString Technologies, the NanoString logo, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.
The GeoMx DSP was used to profile lung tissue collected on autopsy from patients who had succumbed to COVID-19 infection. Researchers used the Cancer Transcriptome Atlas (CTA) plus a spike-in panel to detect additional lung genes and SARS-CoV-2 virus. In total, over 1,800 genes were interrogated as part of the study. This information enabled the researchers to connect bulk RNA sequencing data to the lung tissue's spatial architecture by looking at the distribution and transcriptional activity of cells, providing an important basis for understanding COVID-19 and lung pathology.
The first study, published in Nature Communications and led by Dr. Christopher Mason at Weill Cornell Medicine, was entitled "Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveal unique host responses, viral diversification, and drug interactions." In this study, the GeoMx platform was used to molecularly characterize alveolar lung tissue. The team found spatially-restricted expression of the gene ACE2—which is a SARS-CoV-2 cellular target—and SARS-CoV-2 virus in some of the same regions. From the spatially-resolved expression profiles, they were able to infer the abundance of different immune and non-immune cells and found unique cellular distributions in COVID-19 patients compared to normal control lung samples.
"We were interested in characterizing the diversity of SARS-CoV-2 circulating in the population as well as the diversity of response to infection within a single patient. By using cell-type deconvolution, we were able to measure relative levels of 16 different cell populations from COVID-19 cases and controls using a single slide from each patient," said Dr. Mason, who serves on NanoString's Scientific Advisory Board and is a paid consultant for the company. "This deep molecular profiling helped us create a more complete picture of how the virus circulates in the body and how it elicits a variable response in infected individuals."
More on Washingtoner
- Male In Custody After North Spokane Drive By Shooting
- ZRCalc™ Cinema Card Calculator Now Available for Nikon ZR Shooters
- Revolutionary Data Solution Transforms Health Insurance Underwriting Accuracy
- $36 Million LOI to Acquire High Value Assets from Vivakor Inc in Oklahoma's STACK Play — Building Cash Flow and Scalable Power Infrastructure; $OLOX
- Kobie Wins for AI Innovations in the 2026 Stevie® Awards for Sales & Customer Service
The second study, "The spatial landscape of lung pathology during COVID-19 progression", was published in Nature and was led by Dr. Robert Schwartz, Dr. Alain Borczuk, and Dr. Olivier Elemento at Weill Cornell Medicine. The team found a difference in immune composition between individuals with early (<14 days) versus late (>30 days) mortality after admission to a hospital with COVID-19 symptoms. In "early" patients, immune cells known as neutrophils were seen at rates comparable to other acute respiratory distress syndromes (ARDS). However, with time it appears that a different pattern emerges; namely, increased abundance of macrophages, more inflammation, and wound healing (fibrosis) in patients with late mortality.
"Spatial profiling of the samples allowed us to separately characterize the transcriptional response in the airway, alveolar, and vascular compartments of the lung, and enabled us to see that the early period of severe COVID-19 disease is comprised of inflammatory responses to SARS-CoV-2," said Dr. Schwartz. "We also discovered late COVID-19 might be driven by pathogen-independent mechanisms of an immune response with aberrant resolution."
"These studies demonstrate the value of the GeoMx Digital Spatial Profiler in characterizing the tissue damage induced by SARS-CoV-2 infection," said Sarah Warren, Ph.D., Senior Director of Translational Science at NanoString. "By applying high-plex molecular profiling on the formalin fixed, paraffin embedded (FFPE) tissues that are safe to work with from COVID-19 autopsies, we can understand how the virus is inducing and altering immune response and tissue repair in the patients' lungs."
The GeoMx Digital Spatial Profiler enables researchers to rapidly and quantitatively characterize tissue morphology with a high-throughput, high-plex RNA and protein profiling system that preserves precious samples for future analyses. NanoString and its collaborators have presented DSP data in dozens of abstracts at major scientific meetings, and in more than 40 peer reviewed publications, demonstrating DSP's utility to address a wide range of biological questions in FFPE and frozen tissues. Interested parties can learn more about DSP by visiting https://www.nanostring.com/scientific-content/technology-overview/digital-spatial-profiling-technology.
More on Washingtoner
- Spokane: Shoplifting Incident Becomes A Felony Crime After Store Employee Is Assaulted
- Berman | Sobin | Gross LLP Celebrates 35 Years of Advocating for Maryland's Injured Workers and Families
- Art of Whiskey Hosts 3rd Annual San Francisco Tasting Experience During Super Bowl Week
- PADT Earns Prestigious 2025 Americas Customer Loyalty Award from Ansys, Part of Synopsys
- Florida Keys Visitors Can Save 15 Percent With KeysCaribbean's Advanced Booking Discount
NanoString launched its Technology Access Program (TAP) for the recently announced single and subcellular Spatial Molecular Imager to complement the existing TAP program for GeoMx. Under the program, customers can submit tissue samples to NanoString to be analyzed using both spatial profiling platforms and receive a complete data package. Researchers interested in participating in NanoString's Technology Access Program should contact the company at TAP@nanostring.com.
About NanoString Technologies, Inc.
NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company's nCounter® Analysis System is used in life sciences research and has been cited in more than 4,000 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company's GeoMx® Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections.
For more information, please visit www.nanostring.com.
NanoString, NanoString Technologies, the NanoString logo, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.
0 Comments
Latest on Washingtoner
- Don't Settle for a Lawyer Who Just Speaks Spanish. Demand One Who Understands Your Story
- Dan Williams Promoted to Century Fasteners Corp. – General Manager, Operations
- Ski Johnson Inks Strategic Deals with Three Major Food Chain Brands
- NIL Club Advances Agent-Free NIL Model as Oversight Intensifies Across College Athletics
- As Smart Contract Disputes Average $1.2M, Bilingual Finance Expert Launches Blockchain Legal Translation Services
- Atlanta Magazine Names Dr. Rashad Richey One of Atlanta's Most Influential Leaders in 2026 as the FIFA World Cup Approaches
- Apostle Margelee Hylton Announces the Release of Third Day Prayer
- Slotozilla Reports Strong Q4 Growth and Sigma Rome Success
- "Lights Off" and Laughs On: Joseph Neibich Twists Horror Tropes in Hilariously Demonic Fashion
- Families Gain Clarity: Postmortem Pathology Expands Private Autopsy Services in St. Louis
- Quality Expert Daryl Guberman Shatters Boeing's AS9100 Lies: 25 Years of Evidence Ignored by Media, Governments, and Legal Teams
- Beethoven: Music of Revolution and Triumph - Eroica
- Spokane: 2026 Safe Streets For All (Traffic Calming) Updates
- Amy Turner Receives 2025 ENPY Partnership Builder Award from The Community Foundation
- Hubble Tension Solved? Study finds evidence of an 'Invisible Bias' in How We Measure the Universe
- Boonuspart.ee Acquires Kasiino-boonus.ee to Strengthen Its Position in the Estonian iGaming Market
- Vines of Napa Launches Partnership Program to Bolster Local Tourism and Economic Growth
- Meet Laurent Gabay Global Apparel, Accessories, and Textiles Sourcing — His Firm Fashion Sourcing
- Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies
- Angels Of Dirt Premieres on Youtube, Announces Paige Keck Helmet Sponsorship for 2026 Season